RUXOLITINIB

73257 reported adverse events

Drug classes: Janus Kinase Inhibitor [EPC] Kinase Inhibitor [EPC]

These side effects are most commonly reported by patients taking RUXOLITINIB:

# Side effect Count
0 OFF LABEL USE 15250
1 DEATH 6480
2 FATIGUE 6265
3 ANAEMIA 3164
4 HAEMOGLOBIN DECREASED 3001
5 PRODUCT DOSE OMISSION ISSUE 2806
6 DIARRHOEA 2735
7 PLATELET COUNT DECREASED 2730
8 ASTHENIA 2586
9 DIZZINESS 2557
See all common reactions for RUXOLITINIB

RUXOLITINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DISEASE PROPENSITY 47 0.9400
1 BLOOD ERYTHROPOIETIN ABNORMAL 36 0.6429
2 AQUAGENIC PRURITUS 52 0.6341
3 BRONCHIOLITIS OBLITERANS SYNDROME 63 0.3600
4 CHRONIC GRAFT VERSUS HOST DISEASE IN LUNG 60 0.3468
5 MYELOFIBROSIS 944 0.3119
6 PRIMARY MYELOFIBROSIS 96 0.2981
7 HAEMATOCRIT ABNORMAL 318 0.2585
8 CHRONIC GRAFT VERSUS HOST DISEASE IN EYE 42 0.2069
9 CHRONIC GRAFT VERSUS HOST DISEASE ORAL 45 0.1837
See all enriched reactions for RUXOLITINIB